Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
Americans keep poisoning themselves | Parents charged with murder after son's death | Resistance training & heart attack risk
Tuesday, July 7, 2026
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Editor's Choice: Heart Health

Americans keep poisoning themselves with semaglutide, other weight loss drugs

These incidents became much more common after the FDA started approving GLP-1 drugs for chronic weight management in 2021. 

READ MORE >
Semaglutide (Wegovy) injector pen. Photo by Dave Fornell
Share on Twitter Share on Facebook Share on Linkedin

Americans keep poisoning themselves with semaglutide, other weight loss drugs

Share on Twitter Share on Facebook Share on Linkedin
Semaglutide (Wegovy) injector pen. Photo by Dave Fornell
These incidents became much more common after the FDA started approving GLP-1 drugs for chronic weight management in 2021. 
READ MORE >

Parents charged with murder after 7-year-old son died of heart disease at 255 pounds

The young boy was allegedly living on a diet of potato chips and other unhealthy snacks. One prosecutor described the case as "extraordinary, terrible neglect."  

READ MORE >
handcuffs arrested arrest jail
Share on Twitter Share on Facebook Share on Linkedin

Parents charged with murder after 7-year-old son died of heart disease at 255 pounds

Share on Twitter Share on Facebook Share on Linkedin
handcuffs arrested arrest jail
The young boy was allegedly living on a diet of potato chips and other unhealthy snacks. One prosecutor described the case as "extraordinary, terrible neglect."  
READ MORE >

Resistance training reduces heart attack risk in women

Researchers explored data from more than 117,000 women, tracking several lifestyle habits over an extended period of time.

READ MORE >
exercise aerobic training fitness resistance training older woman
Share on Twitter Share on Facebook Share on Linkedin

Resistance training reduces heart attack risk in women

Share on Twitter Share on Facebook Share on Linkedin
exercise aerobic training fitness resistance training older woman
Researchers explored data from more than 117,000 women, tracking several lifestyle habits over an extended period of time.
READ MORE >

ACC-AHA release first cardiovascular-kidney-metabolic syndrome guidelines

Science shows the deep relationship between cardiac, kidney and metabolism issues that may impact up to 90% of the U.S. population.  

READ MORE >
The stages of cardiovascular-kidney-metabolic syndrome that was included in the new ACC-AHA CKM syndrome guideline.
Share on Twitter Share on Facebook Share on Linkedin

ACC-AHA release first cardiovascular-kidney-metabolic syndrome guidelines

Share on Twitter Share on Facebook Share on Linkedin
The stages of cardiovascular-kidney-metabolic syndrome that was included in the new ACC-AHA CKM syndrome guideline.
Science shows the deep relationship between cardiac, kidney and metabolism issues that may impact up to 90% of the U.S. population.  
READ MORE >

Trump administration warns public about risk of fraudulent testing schemes

Fears about the risk of sudden cardiac arrest are being used to order unnecessary electrocardiogram and echocardiograms for young athletes, according to a new warning from multiple federal agencies. 

READ MORE >
consumer alert cardiovascular testing scam
Share on Twitter Share on Facebook Share on Linkedin

Trump administration warns public about risk of fraudulent testing schemes

Share on Twitter Share on Facebook Share on Linkedin
consumer alert cardiovascular testing scam
Fears about the risk of sudden cardiac arrest are being used to order unnecessary electrocardiogram and echocardiograms for young athletes, according to a new warning from multiple federal agencies. 
READ MORE >

Diabetes drugs improve survival for patients with ‘broken hearts’

However, no significant difference was seen in heart failure hospitalization rates. The study's authors emphasized that more research on this topic is still necessary. 

READ MORE >
broken heart stethoscope Takotsubo syndrome
Share on Twitter Share on Facebook Share on Linkedin

Diabetes drugs improve survival for patients with ‘broken hearts’

Share on Twitter Share on Facebook Share on Linkedin
broken heart stethoscope Takotsubo syndrome
However, no significant difference was seen in heart failure hospitalization rates. The study's authors emphasized that more research on this topic is still necessary. 
READ MORE >

In Case You Missed It

FDA approves first-in-class hypertension drug from AstraZeneca

Baxdrostat, sold by AstraZeneca under the brand name Baxfendy, is now approved to treat hypertension in combination with other antihypertensive medications.

READ MORE >
How aldosterone works to treat hypertension.
Share on Twitter Share on Facebook Share on Linkedin

FDA approves first-in-class hypertension drug from AstraZeneca

Share on Twitter Share on Facebook Share on Linkedin
How aldosterone works to treat hypertension.
Baxdrostat, sold by AstraZeneca under the brand name Baxfendy, is now approved to treat hypertension in combination with other antihypertensive medications.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

AI is gaining ground, but clinicians run the show | Siemens Healthineers doubles down | Electrophysiologist compensation
News Alert: FDA shares warning about heart valve tech after patient death
Cardiologist pay & productivity are up | FDA clears PE thrombectomy devices | Cardiology tech in spotlight | Gore's new approval
Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart
CMS boosts coverage for heart failure tech | FDA approves CardioMEMS updates | LVADs linked to strokes, other risks
M&A activity in cardiology: Exploring key trends | Cardiac PET vs. SPECT | Doctors support Medicare covering TAVR for AR
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme
Trimed Popup